BBT is an enhancer of impaired glucose-stimulated insulin secretion (GSIS). BBT exhibits anti-hyperglycemia activity, and protects beta-cells from cytokine- or streptozotocin (STZ (HY-13753))-induced cell death in type 2 diabetes models. BBT acts function via cAMP/PKA and long-lasting (L-type) voltage-dependent Ca2+ channel/CaMK2 pathway[1].
Molecular Weight:
386.27
Purity:
99.71
CAS Number:
[445000-45-3]
Formula:
C18H12BrNO2S
Target:
Calcium Channel
Application Notes:
MCE Product type: Dedicated for Diverse Library
* VAT and and shipping costs not included. Errors and price changes excepted